{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:36:00Z","timestamp":1794411360968,"version":"4.9.0"},"reference-count":39,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"unspecified","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2025,2,12]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Airway mucus hypersecretion is a key pathophysiological feature in many respiratory diseases and could lead to airway obstruction and repeated infections, consequently accelerating disease progression, which impacts on pulmonary function and quality of life (QoL), highlighting the importance of mucolytic therapy targeting airway mucus hypersecretion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the safety and efficacy of inhalable ambroxol hydrochloride aerosol for adult patients with respiratory diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>An open-label, single-arm, multicentre postmarketing surveillance study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adult patients with acute or chronic respiratory diseases were eligible to receive aerosol inhalation of ambroxol hydrochloride (3\u2009mL and 7.5\u2009mg\/mL) using a nebuliser two times per day given at least 6\u2009hours apart between doses. The treatment lasted for a maximum of 7\u2009days. The primary safety outcome was the frequency and severity of adverse events (AEs), and the primary efficacy outcome was changes in sputum scale scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1201 eligible patients, 1192 received study medication and were included in the full analysis set and the safety set. Any grade AEs occurred in 16.3% of the patients, including serious AEs in four (0.3%) patients. The three most frequent AEs were respiratory symptoms and signs (1.5%), nausea and vomiting (0.8%) and digestive tract symptoms and signs (0.7%). In the full analysis set, the patients showed a mean reduction of 77.6% (95% CI, 75.9% to 79.3%) in the sputum scale score at the end of treatment, with a mean difference of \u22121.7\u00b10.7 from baseline (p&lt;0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Inhalable ambroxol hydrochloride aerosol is well tolerated and effective in easing expectoration and alleviating cough, reducing sputum and improving the QoL of adult patients with acute and chronic respiratory diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ChiCTR2100043736.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2023-002096","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:35:13Z","timestamp":1747175713000},"page":"e002096","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Safety and efficacy of inhalable ambroxol hydrochloride aerosol for adult patients with respiratory diseases: an open-label, single-arm, multicentre study"],"prefix":"10.1136","volume":"12","author":[{"given":"Jinfang","family":"Ma","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2483-7285","authenticated-orcid":false,"given":"Jinping","family":"Zheng","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Chen","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Shenyang Medical College, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengguang","family":"He","sequence":"additional","affiliation":[{"name":"The Third People\u2019s Hospital of Suining, Suining, Sishuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuke","family":"Xiao","sequence":"additional","affiliation":[{"name":"Jiangxi Provincial People\u2019s Hospital, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Yang","sequence":"additional","affiliation":[{"name":"People\u2019s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[{"name":"The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changli","family":"Yu","sequence":"additional","affiliation":[{"name":"North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianli","family":"Wang","sequence":"additional","affiliation":[{"name":"The First People\u2019s Hospital of Changde City, Changde, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Jinhua Municipal Central Hospital, Jinhua, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangping","family":"Mao","sequence":"additional","affiliation":[{"name":"Chongqing University Three Gorges Hospital, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenshan","family":"Wang","sequence":"additional","affiliation":[{"name":"The Second Hospital of Dalian Medical University, Dalian, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoju","family":"Zhang","sequence":"additional","affiliation":[{"name":"Henan Provincial People\u2019s Hospital, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Meng","sequence":"additional","affiliation":[{"name":"The Third Xiangya Hospital of Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwei","family":"Ye","sequence":"additional","affiliation":[{"name":"Guizhou Provincial People\u2019s Hospital, Guiyang, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Zhao","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[{"name":"China-Japan Friendship Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keying","family":"Xue","sequence":"additional","affiliation":[{"name":"The Second Hospital of Xiamen Medical College, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"He","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baosong","family":"Xie","sequence":"additional","affiliation":[{"name":"Fujian Provincial Hospital, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Chen","sequence":"additional","affiliation":[{"name":"The Central Hospital of Yongzhou, Yongzhou, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhongda Hospital Southeast University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanlin","family":"Song","sequence":"additional","affiliation":[{"name":"Zhongshan Hospital Affiliated to Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiquan","family":"Liang","sequence":"additional","affiliation":[{"name":"The Second People\u2019s Hospital of Foshan, Foshan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Su","sequence":"additional","affiliation":[{"name":"The Fourth People\u2019s Hospital of Jinan, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Zhu","sequence":"additional","affiliation":[{"name":"Huadong Hospital Affiliated to Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjun","family":"Yu","sequence":"additional","affiliation":[{"name":"The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Sun","sequence":"additional","affiliation":[{"name":"Zhejiang Provincial People\u2019s Hospital, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Ren","sequence":"additional","affiliation":[{"name":"Shaanxi Provincial People\u2019s Hospital, Xi\u2019an, Shaanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faguang","family":"Jin","sequence":"additional","affiliation":[{"name":"Tangdu Hospital Affiliated to Air Force Military Medical University, Xi\u2019an, Shannxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Shandong Provincial Hospital, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantuo","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Hu","sequence":"additional","affiliation":[{"name":"The Central Hospital of Wuhan, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhancheng","family":"Gao","sequence":"additional","affiliation":[{"name":"Peking University People's Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongping","family":"Chen","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"2026010701502196000_12.1.e002096.1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069679","article-title":"Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019","volume":"378","author":"Safiri","year":"2022","journal-title":"BMJ"},{"key":"2026010701502196000_12.1.e002096.2","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2019.1576"},{"key":"2026010701502196000_12.1.e002096.3","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1066804","article-title":"Global, regional, and national burden of chronic respiratory diseases and associated risk factors, 1990-2019: Results from the Global Burden of Disease Study 2019","volume":"10","author":"Chen","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"2026010701502196000_12.1.e002096.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0910061"},{"key":"2026010701502196000_12.1.e002096.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.12.046"},{"key":"2026010701502196000_12.1.e002096.6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.chest.2019.06.023","article-title":"Do Cough and Sputum Production Predict COPD Exacerbations?: The Evidence Is Growing","volume":"156","author":"Martin","year":"2019","journal-title":"Chest"},{"key":"2026010701502196000_12.1.e002096.7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2062"},{"key":"2026010701502196000_12.1.e002096.8","first-page":"1134","article-title":"Physiology of airway mucus secretion and pathophysiology of hypersecretion","volume":"52","author":"Rogers","year":"2007","journal-title":"Respir Care"},{"key":"2026010701502196000_12.1.e002096.9","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00004.2021"},{"key":"2026010701502196000_12.1.e002096.10","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.04087"},{"key":"2026010701502196000_12.1.e002096.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043891"},{"key":"2026010701502196000_12.1.e002096.12","first-page":"3192","article-title":"Factorial analysis of N-acetylcysteine and propolis treatment effects on symptoms, life quality and exacerbations in patients with Chronic Obstructive Pulmonary Disease (COPD): a randomized, double-blind, placebo-controlled trial","volume":"26","author":"Kolarov","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026010701502196000_12.1.e002096.13","doi-asserted-by":"crossref","first-page":"106190","DOI":"10.1016\/j.rmed.2020.106190","article-title":"Use of mucolytics in COPD: A Delphi consensus study","volume":"175","author":"Papi","year":"2020","journal-title":"Respir Med"},{"key":"2026010701502196000_12.1.e002096.14","unstructured":"Global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD) 2019. 2019."},{"key":"2026010701502196000_12.1.e002096.15","doi-asserted-by":"crossref","unstructured":"Huang C , Kuo S , Lin L , et al . The efficacy of N-acetylcysteine in chronic obstructive pulmonary disease patients: a meta-analysis. Ther Adv Respir Dis 2023;17. doi:10.1177\/17534666231158563","DOI":"10.1177\/17534666231158563"},{"key":"2026010701502196000_12.1.e002096.16","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.4.8.1119"},{"key":"2026010701502196000_12.1.e002096.17","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1517\/17460441.2011.629646","article-title":"Ambroxol: a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhood","volume":"6","author":"Paleari","year":"2011","journal-title":"Expert Opin Drug Discov"},{"key":"2026010701502196000_12.1.e002096.18","first-page":"557","article-title":"Antiinflammatory properties of ambroxol","volume":"13","author":"Beeh","year":"2008","journal-title":"Eur J Med Res"},{"key":"2026010701502196000_12.1.e002096.19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4110\/in.2016.16.3.165","article-title":"Immunomodulatory Effects of Ambroxol on Airway Hyperresponsiveness and Inflammation","volume":"16","author":"Takeda","year":"2016","journal-title":"Immune Netw"},{"key":"2026010701502196000_12.1.e002096.20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejphar.2016.02.030","article-title":"Ambroxol inhalation ameliorates LPS-induced airway inflammation and mucus secretion through the extracellular signal-regulated kinase 1\/2 signaling pathway","volume":"775","author":"Zhang","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"2026010701502196000_12.1.e002096.21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/17425255.2019.1578748","article-title":"Enhancement of lung levels of antibiotics by ambroxol and bromhexine","volume":"15","author":"Deretic","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2026010701502196000_12.1.e002096.22","doi-asserted-by":"publisher","DOI":"10.1159\/000195274"},{"key":"2026010701502196000_12.1.e002096.23","doi-asserted-by":"crossref","first-page":"174192","DOI":"10.1016\/j.ejphar.2021.174192","article-title":"Antitussive effects of NaV 1.7 blockade in Guinea pigs","volume":"907","author":"Yu","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"2026010701502196000_12.1.e002096.24","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2018.1533954"},{"key":"2026010701502196000_12.1.e002096.25","first-page":"715","article-title":"Long-term therapy over 2 years with ambroxol (Mucosolvan) retard capsules in patients with chronic bronchitis. Results of a double-blind study of 180 patients","volume":"42","author":"Cegla","year":"1988","journal-title":"Prax Klin Pneumol"},{"key":"2026010701502196000_12.1.e002096.26","first-page":"700","article-title":"Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol","volume":"50","author":"Matthys","year":"2000","journal-title":"Arzneimittelforschung"},{"key":"2026010701502196000_12.1.e002096.27","first-page":"5019","article-title":"Aerosol inhalation of ambroxol hydrochloride combined with terbutaline can promote recovery of children with severe pneumonia","volume":"13","author":"Yu","year":"2021","journal-title":"Am J Transl Res"},{"key":"2026010701502196000_12.1.e002096.28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21037\/tp-21-516","article-title":"Efficacy of phentolamine combined with ambroxol aerosol inhalation in the treatment of pediatric severe pneumonia and its effect on serum IL-10 and CRP levels","volume":"11","author":"Li","year":"2022","journal-title":"Transl Pediatr"},{"key":"2026010701502196000_12.1.e002096.29","first-page":"26","article-title":"Study on the effect of budesonide combined with ambroxol aerosol inhalation on the treatment of acute bronchitis and on pulmonary function in patients","volume":"128","author":"Du","year":"2021","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2026010701502196000_12.1.e002096.30","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199711000-00002"},{"key":"2026010701502196000_12.1.e002096.31","first-page":"7","article-title":"Efficacy and Safety of Ambroxol Injection by Inhalation Versus Intravenous Administration: A Systematic Review","volume":"28","author":"Lu","year":"2018","journal-title":"Pharmacy Today"},{"key":"2026010701502196000_12.1.e002096.32","first-page":"1284","article-title":"Clinical efficacy of atomizing inhalation of ambroxol hydrochloride in treatment of chronic bronchitis in elderly patients","volume":"38","author":"Dong","year":"2019","journal-title":"Lat AM J Pharm"},{"key":"2026010701502196000_12.1.e002096.33","first-page":"248","article-title":"Ambroxol therapy in simple chronic bronchitis: effects on subjective symptoms and ventilatory function","volume":"69","author":"Ericsson","year":"1986","journal-title":"Eur J Respir Dis"},{"key":"2026010701502196000_12.1.e002096.34","doi-asserted-by":"publisher","DOI":"10.1159\/000195273"},{"key":"2026010701502196000_12.1.e002096.35","first-page":"859","article-title":"Mucolytics, expectorants, and mucokinetic medications","volume":"52","author":"Rubin","year":"2007","journal-title":"Respir Care"},{"key":"2026010701502196000_12.1.e002096.36","doi-asserted-by":"crossref","DOI":"10.1186\/2213-0802-2-6","article-title":"Secretion properties, clearance, and therapy in airway disease","volume":"2","author":"Rubin","year":"2014","journal-title":"Transl Respir Med"},{"key":"2026010701502196000_12.1.e002096.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2003.08.004"},{"key":"2026010701502196000_12.1.e002096.38","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0141-2022","article-title":"Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis","volume":"32","author":"Papadopoulou","year":"2023","journal-title":"Eur Respir Rev"},{"key":"2026010701502196000_12.1.e002096.39","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7525-5-70","article-title":"Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer","volume":"5","author":"Pickard","year":"2007","journal-title":"Health Qual Life Outcomes"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2023-002096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:50:56Z","timestamp":1767779456000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2023-002096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,5,13]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/bmjresp-2023-002096"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2023-002096","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}